High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors Read more about High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors Canada3156761Filed on 2020-10-21
High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors Read more about High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors Australia2020370125Filed on 2020-10-21
VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS Read more about VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS European Patent22157548.3Filed on 2022-02-18
T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Read more about T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Patent Cooperation TreatyPCT/US2022/028066Filed on 2022-05-06
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION Patent Cooperation TreatyPCT/US2022/025177Filed on 2022-04-18
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT Read more about METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT United Kingdom17805342.7Filed on 2019-05-06
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT Read more about METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT Germany17805342.7Filed on 2019-05-06
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT Read more about METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT France17805342.7Filed on 2019-05-06
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US Application 17/692,787Filed on 2022-03-11
CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer Read more about CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer Japan2022-22792Filed on 2022-02-17